1Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
2Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
3Department of Optometry, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran
4London Vision Clinic, London, United Kingdom
5Columbia University Medical Center, New York, New York
6Sorbonne Université, Paris, France
7Biomedical Science Research Institute, Ulster University, Coleraine, United Kingdom
∗[email protected]
Submitted: May 23, 2021
Accepted: January 30, 2022
Funding/Support: None of the authors have reported funding/support.
Conflict of Interest Disclosure: DZR is a consultant for Carl Zeiss Meditec (Carl Zeiss Meditec AG, Jena, Germany) and has a proprietary interest in the Artemis Insight 100 technology (ArcScan Inc., Golden, CO) through patents administered by the Cornell Center for Technology Enterprise and Commercialization, Ithaca, NY. The remaining authors have no proprietary or financial interest in the materials presented herein.
Author Contributions and Acknowledgments: Conceptualization: M-RS, HM-M, AA, DZR; Data Curation: M-RS, HM-M, OS; Formal Analysis: HM-M, OS, DZR, RSV; Investigation: HM-M, AA, RSV; Methodology: HM-M, OS; Project Administration: HM-M, AA, OS; Resources: HM-M; Supervision: M-RS, HM-M, AA; Validation: HM-M; Visualization: HM-M; Writing – Original Draft: M-RS, HM-M, AA, OS, DZR, RSV; Writing – Review & Editing: M-RS, HM-M, AA, DZR, RSV.
The authors would like to thank the personnel of Sedaghat Eye Clinic, the participants who made this study possible, and the Deputy of Research of the Mashhad University of Medical Sciences (Ethic Code No.: IR.MUMS.REC.1398.073).
